Janus Henderson Group PLC Akero Therapeutics, Inc. Put Options Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
299Shares Held
92.3MCall Options Held
1.72MPut Options Held
901K-
General Atlantic LLC New York, NY5.73MShares$311 Million10.64% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$303 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.48MShares$297 Million4.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$246 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.51MShares$245 Million0.03% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.52B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...